Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants
Conditions
- Immunocompromised Patients
- Safety of Pandemic Influenza A (H1N1)Vaccine
- Immunogenicity of Pandemic Influenza A (H1N1)Vaccine
Interventions
- BIOLOGICAL: Split inactivated A/California/7/2009 (H1N1) (NYMC X-179A) VIRUS
Sponsor
Butantan Institute
Collaborators
- [object Object]
- [object Object]
- [object Object]